2.1.1.6: catechol O-methyltransferase
This is an abbreviated version!
For detailed information about catechol O-methyltransferase, go to the full flat file.
Word Map on EC 2.1.1.6
-
2.1.1.6
-
dopamine
-
val158met
-
catechols
-
parkinson
-
monoamine
-
dopaminergic
-
schizophrenia
-
prefrontal
-
levodopa
-
estrogen
-
val
-
o-methylation
-
psychiatric
-
norepinephrine
-
entacapone
-
l-dopa
-
tolcapone
-
serotonin
-
noradrenaline
-
dyskinesia
-
neurotransmitter
-
striatal
-
psycho
-
dopac
-
carbidopa
-
verbal
-
3,4-dihydroxyphenylacetic
-
extraneuronal
-
5-httlpr
-
low-activity
-
parkinsonian
-
homovanillic
-
normetanephrine
-
benserazide
-
antiparkinsonian
-
synthesis
-
endophenotype
-
dsm-iv
-
3h-noradrenaline
-
2-methoxyestradiol
-
analysis
-
tropolone
-
updrs
-
slc6a4
-
dihydroxyphenylacetic
-
amantadine
-
pargyline
-
oxidase-b
-
phenylethanolamine-n-methyltransferase
-
metanephrine
-
selegiline
-
medicine
-
antisocial
- 2.1.1.6
- dopamine
-
val158met
- catechols
- parkinson
-
monoamine
-
dopaminergic
-
schizophrenia
-
prefrontal
- levodopa
- estrogen
- val
-
o-methylation
-
psychiatric
- norepinephrine
- entacapone
- l-dopa
- tolcapone
- serotonin
- noradrenaline
- dyskinesia
-
neurotransmitter
- striatal
-
psycho
-
dopac
- carbidopa
-
verbal
-
3,4-dihydroxyphenylacetic
-
extraneuronal
-
5-httlpr
-
low-activity
-
parkinsonian
-
homovanillic
- normetanephrine
- benserazide
-
antiparkinsonian
- synthesis
-
endophenotype
-
dsm-iv
-
3h-noradrenaline
- 2-methoxyestradiol
- analysis
- tropolone
-
updrs
-
slc6a4
-
dihydroxyphenylacetic
- amantadine
- pargyline
-
oxidase-b
-
phenylethanolamine-n-methyltransferase
- metanephrine
- selegiline
- medicine
-
antisocial
Reaction
Synonyms
catechol methyltransferase, catechol-O-methyl transferase, catechol-O-methyl transferase, membrane bound, catechol-O-methyl transferase, soluble, catechol-O-methyltransferase, catechol-O-transferase, catecholamine O-methyltransferase, COMT, COMT I, COMT II, COMT-mb, COMT-s, COMT1, COMT2, CTOMT1, L-COMT, MB-COMT, methyltransferase, catechol, S-COMT, SCOMT
ECTree
Advanced search results
Engineering
Engineering on EC 2.1.1.6 - catechol O-methyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
C95S
-
mutation increases the activity measured in absence of dithiothreitol in both the 108V and the 108M variant
V108M
V158M
the mutation affects directly COMT enzyme activity, the COMT polymorphism is unconnected to cold pain
Y71X
-
the mutation is predicted to truncate the protein before the catalytic domain likely affecting methyltransferase activity
K144A
mutation of the proposed catalytic Lys residue, does not abolish COMT activity
W38D
mutation of hydrophobic pocket, approximately +93% regioisomeric excess, and around 50% conversion of substrate 3,4-dihydroxybenzaldehyde
W38K
mutant favors para- over meta-methylation of dihydroxy substrates
W38R
mutant favors para- over meta-methylation of dihydroxy substrates
Y200L
mutant favors meta- over para-methylation of dihydroxy substrates, and exhibits the greatest meta-selectivity whilst retaining relative activity similar to that of the wild-type
I56A
dissociation constant of S-adenosylmethionine is similar to wild-type. Residue I56 forms a pair of H-bonds with oxygen in the methionine portion
W164A
dissociation constant of S-adenosylmethionine is similar to wild-type. Residue W164 forms a T-shaped pi-pi interaction with the adenine ring
W164A
-
dissociation constant of S-adenosylmethionine is similar to wild-type. Residue W164 forms a T-shaped pi-pi interaction with the adenine ring
-
additional information
the mutation decreases the structural stability of catechol O-methyltransferase, the mutant loses enzymatic activity more rapidly than the wild type enzyme at physiological temperature, the midpoint of the thermal transition of V108M is 5-7°C lower than that of wild type enzyme, and the free energy of unfolding at 25°C is smaller by about 0.4 kcal/mol, the mutant also iss more prone to aggregation or partial unfolding to a form with an increased radius of hydration at 37°C. The mutation is associated with increased risk of breast cancer and several neuropsychiatric disorders,
-
genetic variation in the catechol-O-methyltansferase enzyme is associated independently with morphine-related central side effects in cancer patients, such as drowsiness, confusion, and hallucinations. Single nucleotide polymorphisms in intron 1 are associated significantly with these central side effects, the most significant is at position 24873G
additional information
-
the add mutation substantially diminishes COMT1 methyltransferase activity toward norepinephrine